Daniel Alvarenga Fernandes, Daniel Bohn, Pedro Antune da Silva Pereira, Mila Mucci, Vittor Hugo Andrade Marques, Paula Juliano Lopes de Faria, Elaine Cristina de Ataide, João Rafael Terneira Vicentini, Nelson Marcio Gomes Caserta, Ilka de Fátima Santana Ferreira Boin
{"title":"基于计算机断层扫描的肝移植术后肌肉减少症筛查和死亡率:一项系统回顾和荟萃分析。","authors":"Daniel Alvarenga Fernandes, Daniel Bohn, Pedro Antune da Silva Pereira, Mila Mucci, Vittor Hugo Andrade Marques, Paula Juliano Lopes de Faria, Elaine Cristina de Ataide, João Rafael Terneira Vicentini, Nelson Marcio Gomes Caserta, Ilka de Fátima Santana Ferreira Boin","doi":"10.1590/1806-9282.20241672","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The aim of this study was to investigate the diagnosis of sarcopenia in chronic liver disease by opportunistic computed tomography screening using the Psoas Muscle Index method as a predictor of mortality after liver transplantation.</p><p><strong>Methods: </strong>We systematically searched PubMed, Scopus, and Cochrane Central Register of Controlled Trials from July 2014 to July 2024. We restricted inclusion in this meta-analysis to observational studies and clinical trials on adult patients with chronic liver disease diagnosed with sarcopenia by computed tomography undergoing liver transplantation or on a waiting list. We included the one with a larger sample size for studies with overlapping populations. We excluded studies with therapeutic interventions, animal experiments, cell-line studies, editorial pieces, commentaries, review articles, and case reports.</p><p><strong>Results: </strong>After the removal of duplicate records and ineligible studies, 163 remained and were thoroughly reviewed based on inclusion criteria. Of these, a total of 11 studies were included in qualitative synthesis and four studies were included in quantitative analysis (meta-analysis), comprising 382 patients. Patients with muscle mass loss after liver transplantation diagnosed by computed tomography scan using the Psoas Muscle Index method had a 4.1 times higher risk of death than non-sarcopenic patients (random-effects model: OR 4.1386; 95%CI 2.4215-7.0730; p<0.0001). Interpretatively, a scale with an I2 value close to 0% indicates no heterogeneity. The other criteria also did not reject the hypothesis of homogeneity among the articles.</p><p><strong>Conclusions: </strong>Patients with muscle mass loss diagnosed by computed tomography using the Psoas Muscle Index method had a fourfold increased mortality risk after transplantation. The findings reinforce the need to identify sarcopenic patients preoperatively to optimize liver transplantation outcomes. Using the Psoas Muscle Index, an opportunistic diagnosis by computed tomography scan can be helpful in this setting.</p>","PeriodicalId":94194,"journal":{"name":"Revista da Associacao Medica Brasileira (1992)","volume":"71 6","pages":"e20241672"},"PeriodicalIF":1.3000,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12245067/pdf/","citationCount":"0","resultStr":"{\"title\":\"Opportunistic computed tomography-based sarcopenia screening and mortality after liver transplantation: a systematic review and meta-analysis.\",\"authors\":\"Daniel Alvarenga Fernandes, Daniel Bohn, Pedro Antune da Silva Pereira, Mila Mucci, Vittor Hugo Andrade Marques, Paula Juliano Lopes de Faria, Elaine Cristina de Ataide, João Rafael Terneira Vicentini, Nelson Marcio Gomes Caserta, Ilka de Fátima Santana Ferreira Boin\",\"doi\":\"10.1590/1806-9282.20241672\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>The aim of this study was to investigate the diagnosis of sarcopenia in chronic liver disease by opportunistic computed tomography screening using the Psoas Muscle Index method as a predictor of mortality after liver transplantation.</p><p><strong>Methods: </strong>We systematically searched PubMed, Scopus, and Cochrane Central Register of Controlled Trials from July 2014 to July 2024. We restricted inclusion in this meta-analysis to observational studies and clinical trials on adult patients with chronic liver disease diagnosed with sarcopenia by computed tomography undergoing liver transplantation or on a waiting list. We included the one with a larger sample size for studies with overlapping populations. We excluded studies with therapeutic interventions, animal experiments, cell-line studies, editorial pieces, commentaries, review articles, and case reports.</p><p><strong>Results: </strong>After the removal of duplicate records and ineligible studies, 163 remained and were thoroughly reviewed based on inclusion criteria. Of these, a total of 11 studies were included in qualitative synthesis and four studies were included in quantitative analysis (meta-analysis), comprising 382 patients. Patients with muscle mass loss after liver transplantation diagnosed by computed tomography scan using the Psoas Muscle Index method had a 4.1 times higher risk of death than non-sarcopenic patients (random-effects model: OR 4.1386; 95%CI 2.4215-7.0730; p<0.0001). Interpretatively, a scale with an I2 value close to 0% indicates no heterogeneity. The other criteria also did not reject the hypothesis of homogeneity among the articles.</p><p><strong>Conclusions: </strong>Patients with muscle mass loss diagnosed by computed tomography using the Psoas Muscle Index method had a fourfold increased mortality risk after transplantation. The findings reinforce the need to identify sarcopenic patients preoperatively to optimize liver transplantation outcomes. Using the Psoas Muscle Index, an opportunistic diagnosis by computed tomography scan can be helpful in this setting.</p>\",\"PeriodicalId\":94194,\"journal\":{\"name\":\"Revista da Associacao Medica Brasileira (1992)\",\"volume\":\"71 6\",\"pages\":\"e20241672\"},\"PeriodicalIF\":1.3000,\"publicationDate\":\"2025-07-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12245067/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista da Associacao Medica Brasileira (1992)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1590/1806-9282.20241672\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista da Associacao Medica Brasileira (1992)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1590/1806-9282.20241672","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
目的:本研究的目的是利用腰肌指数方法作为肝移植后死亡率的预测指标,探讨机会性计算机断层扫描对慢性肝病肌肉减少症的诊断。方法:系统检索2014年7月至2024年7月PubMed、Scopus和Cochrane Central Register of Controlled Trials。我们将观察性研究和临床试验纳入本荟萃分析,这些观察性研究和临床试验是通过计算机断层扫描诊断为肌肉减少症的慢性肝病成年患者,这些患者正在接受肝移植或在等待名单上。我们在重叠人群的研究中纳入了样本量较大的一个。我们排除了治疗性干预研究、动物实验、细胞系研究、社论、评论、综述文章和病例报告。结果:在删除重复记录和不符合条件的研究后,163项研究被保留下来,并根据纳入标准进行了彻底的审查。其中,共有11项研究纳入定性综合,4项研究纳入定量分析(meta分析),共382例患者。使用腰肌指数方法进行计算机断层扫描诊断为肝移植后肌肉量减少的患者的死亡风险是非肌肉减少患者的4.1倍(随机效应模型:OR 4.1386;95%可信区间2.4215 - -7.0730;结论:使用腰肌指数方法通过计算机断层扫描诊断出肌肉质量下降的患者移植后死亡风险增加4倍。研究结果加强了术前识别肌肉减少患者以优化肝移植结果的必要性。使用腰肌指数,计算机断层扫描的机会性诊断在这种情况下是有帮助的。
Opportunistic computed tomography-based sarcopenia screening and mortality after liver transplantation: a systematic review and meta-analysis.
Objective: The aim of this study was to investigate the diagnosis of sarcopenia in chronic liver disease by opportunistic computed tomography screening using the Psoas Muscle Index method as a predictor of mortality after liver transplantation.
Methods: We systematically searched PubMed, Scopus, and Cochrane Central Register of Controlled Trials from July 2014 to July 2024. We restricted inclusion in this meta-analysis to observational studies and clinical trials on adult patients with chronic liver disease diagnosed with sarcopenia by computed tomography undergoing liver transplantation or on a waiting list. We included the one with a larger sample size for studies with overlapping populations. We excluded studies with therapeutic interventions, animal experiments, cell-line studies, editorial pieces, commentaries, review articles, and case reports.
Results: After the removal of duplicate records and ineligible studies, 163 remained and were thoroughly reviewed based on inclusion criteria. Of these, a total of 11 studies were included in qualitative synthesis and four studies were included in quantitative analysis (meta-analysis), comprising 382 patients. Patients with muscle mass loss after liver transplantation diagnosed by computed tomography scan using the Psoas Muscle Index method had a 4.1 times higher risk of death than non-sarcopenic patients (random-effects model: OR 4.1386; 95%CI 2.4215-7.0730; p<0.0001). Interpretatively, a scale with an I2 value close to 0% indicates no heterogeneity. The other criteria also did not reject the hypothesis of homogeneity among the articles.
Conclusions: Patients with muscle mass loss diagnosed by computed tomography using the Psoas Muscle Index method had a fourfold increased mortality risk after transplantation. The findings reinforce the need to identify sarcopenic patients preoperatively to optimize liver transplantation outcomes. Using the Psoas Muscle Index, an opportunistic diagnosis by computed tomography scan can be helpful in this setting.